Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain

NCT01167699 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
174
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mundipharma Pharmaceuticals B.V.